Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study

Existing literature examining warfarin's association with prostate cancer (PCa) risk provides conflicting results, while the association with direct oral anticoagulants (DOACs) has not yet been studied. We investigated the association of warfarin and DOAC use on PCa risk among men within the po...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Jonathan, Crawley, Danielle, Garmo, Hans, Lindahl, Bertil, Styrke, Johan, Adolfsson, Jan, Lambe, Mats, Stattin, Pär, Van Hemelrijck, Mieke, Beckmann, Kerri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578339/
https://www.ncbi.nlm.nih.gov/pubmed/33134172
http://dx.doi.org/10.3389/fonc.2020.571838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578339/
https://www.ncbi.nlm.nih.gov/pubmed/33134172
http://dx.doi.org/10.3389/fonc.2020.571838

Ejemplares similares